Mark A. Gill - Concepedia

Author

Mark A. Gill

University of Southern California

Also Known As

M A Gill, MARK A. GILL, Mark .A. Gill, Mark A Gill, Mark A. Gill, Mark Anthony Gill, Mark Gill

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Southern California LAC+USC Medical Center University of Oslo Meijo University City of Hope

About

Mark A. Gill is an author at University of Southern California specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	436
2	Health Sciences	2	2	108
3	Biochemistry	2	2	107
4	Engineering	1	1	14
5	Biomolecular Engineering	1	1	14

Mark A. Gill

Publications

802

Citations

H-Index

Page 1

	Year	Citations
Population Pharmacokinetics and Use of Monte Carlo Simulation To Evaluate Currently Recommended Dosing Regimens of Ciprofloxacin in Adult Patients with Cystic Fibrosis Megan J. Montgomery, Paul M. Beringer, Amir Aminimanizani, Antimicrobial Agents and Chemotherapy	2001	59
Absolute Bioavailability and Intracellular Pharmacokinetics of Azithromycin in Patients with Cystic Fibrosis Paul M. Beringer, Kitty My Tu Huynh, Jane Kriengkauykiat, Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityHealth SciencesAntibioticsAbsolute BioavailabilityPharmacology	2005	57
Determination of Fluconazole in Human Serum by Solid-Phase Extraction and Reversed-Phase High-Performance Liquid Chromatography Kazuhiro Inagaki, Jane Takagi, Edward Lor, Therapeutic Drug Monitoring Ultraviolet AbsorptionBiochemistrySeparation ScienceMedicineGas Chromatography	1992	56
Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings Paul M. Beringer, Megan Nguyen, Nils Hoem, Antimicrobial Agents and Chemotherapy	2005	53
Cefepime: A new fourth-generation cephalosporin Mark P. Okamoto, Randall K. Nakahiro, Alfred Chin, American Journal of Health-System Pharmacy Antibiotic AdjuvantAntimicrobial ChemotherapyDrug ResistanceMedical MicrobiologyMedicinal Chemistry	1994	51
Imipenem Levels Are Not Predictable in the Critically Ill Patient Howard Belzberg, Jay Zhu, Edward E. Cornwell, The Journal of Trauma: Injury, Infection, and Critical Care	2004	46
Altered gentamicin distribution in ascitic patients Mark A. Gill, Jack W. Kern American Journal of Health-System Pharmacy Renal FunctionAltered Gentamicin DistributionPharmacologyGentamicin DosageLaboratory Medicine	1979	42
Utility of a transdermal delivery system for antihypertensive therapy. Part 1 David A. Sclar, Tracy L. Skaer, Alfred Chin, The American Journal of Medicine HypertensionTransdermal Delivery SystemAntihypertensive TherapyVascular SurgerySurgery	1991	41
Stability and Antibacterial Activity of Cefepime during Continuous Infusion Pål F. Sprauten, Paul M. Beringer, Stan G. Louie, Antimicrobial Agents and Chemotherapy	2003	37
A Comparison of Aztreonam and Clindamycin versus Gentamicin and Clindamycin Thomas V. Berne, Maria D. Appleman, Frank C. Chenella, Annals of Surgery G/c PatientsAntibioticsMedicinePerforated AppendicitisAntibiotic Adjuvant	1987	37

Page 1